Tech Company Inital Public Offerings
Concert Pharmaceuticals IPO
On 2/13/2014, Concert Pharmaceuticals went public.
Transaction Overview
Company Name
Announced On
2/13/2014
Transaction Type
IPO
Amount
$84,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
99 Hayden Ave. 500
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Website
Email Address
Overview
Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform to create novel small molecule drugs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Roger Tung
Chief Financial Officer
Marc Becker
Chief Operating Officer
Nancy Stuart
VP - Bus. Development
James Cassella
Browse more venture capital transactions:
Prev: 2/13/2014: RiseSmart venture capital transaction
Next: 2/13/2014: WorkFlex Solutions venture capital transaction
Share this article
Where The Data Comes From
We do our best to record tech company VC transactions. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs